• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says
next post
J&J reaches sweeping talc deal that could end decade of litigation

related articles

Springsteen, other stars share stage with hardcore leftist...

October 5, 2026

Trump drops Republican Senator’s phone number in social...

October 5, 2026

Firebrand GOP rep: Democrats side with Iran ‘simply...

October 5, 2026

Tennessee prison chief resigns after failed execution as...

October 5, 2026

State’s largest mosque leader’s deportation fight takes dramatic...

October 1, 2026

Trump handing 1 million Americans Obamacare refund checks...

October 1, 2026

Iranian negotiators kicked out of US as talks...

October 1, 2026

10 Democrat-held House seats Republicans could flip to...

October 1, 2026

Trump’s new high-tech government hub holds some bizarre...

October 1, 2026

Biden-era federal prosecutor hit with criminal investigation referral...

October 1, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Teen’s tragic killing by illegal immigrant becomes flashpoint in battle for control of Congress

    October 1, 2026
  • Iran’s biggest weapon against the US may be slipping away, experts say

    July 10, 2026
  • Coinbase stock falls as Baird flags weak trading volumes and valuation risks

    June 5, 2026
  • SK Hynix stock tumbles 11% again: when will this boom-bust cycle finally end?

    July 16, 2026
  • Micron to invest up to $3B in US chip supply chain, stock jumps on AI optimism

    July 9, 2026

Popular Posts

  • 1

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 2

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 3

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 4

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (711)
  • Investing (1,932)
  • Stock (90)

Latest Posts

  • SK Hynix to raise $29.4B in US listing: How it may impact the AI memory chip trade

    June 24, 2026
  • Election crime arrests keep piling up as Dems insist it ‘just doesn’t happen’

    October 1, 2026
  • Micron, Intel, two other stocks to lead pack as BofA sees $3.2T semis market by 2030

    September 16, 2026

Recent Posts

  • From SpaceX to Apple: how the tech-led AI rally suffered many blows this week and why

    June 26, 2026
  • SpaceX stock closes below its IPO price for the first time since it went public

    July 19, 2026
  • Why is BlackRock cutting US stock exposure and upgrading Treasuries now

    October 13, 2026

Editor’s Pick

  • Dow rises 380 points as investors await Fed decision, SpaceX extends rally

    June 16, 2026
  • Trump wins two, loses one: Georgia billionaire delivers rare blow to endorsement machine

    June 17, 2026
  • Intel stock jumps on BofA upgrade as AI demand fuels growth outlook

    June 11, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock